FET: CREB fusions have been described in a variety of tumors from various phenotypes.
Recently, these fusion transcripts were reported in intracranial tumors, variably named …

Abstract 'Intracranial mesenchymal tumor, FET‐CREB fusion‐positive'occurs primarily in
children and young adults and has previously been termed intracranial angiomatoid fibrous …

Intracranial mesenchymal tumors with FET‐CREB fusions are a recently described group of
neoplasms in children and young adults characterized by fusion of a FET family gene …

Intracranial mesenchymal tumor (IMT), FET:: CREB fusion-positive is a provisional tumor
type in the 2021 WHO classification of central nervous system tumors with limited …

Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft tissue neoplasm that can
exhibit diverse morphological features, including myxoid change. Rarely, the tumor occurs …

Intracranial myxoid mesenchymal tumor (IMMT) is a recently described, extremely rare
group of neoplasms characterized by fusions between the female‐expressed transcript …

Intracranial myxoid mesenchymal tumor harboring EWSR1 fusions with CREB family of
genes was recently described, and it resembles the myxoid variant of angiomatoid fibrous …

Angiomatoid fibrous histiocytomas (AFH) is a rare soft tissue tumor of intermediate malignant
potential, and its histology is diverse. It can occur in several organs including intracranial …

Translocations between EWSR1 and members of the CREB family of transcription factors
(CREB1, ATF1, and CREM) are rare genetic findings occurring in various sarcomas. Of …

Gene fusions of EWSR1 with members of the CREB family of transcription factors (CREB1,
ATF1, and CREM) have recently been described in exceptional intracranial myxoid …